Medtronic plc
MDT · NYSE
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Market Cap | $108,967 | $106,535 | $120,586 | $140,093 |
| - Cash | $2,218 | $1,284 | $1,543 | $3,714 |
| + Debt | $28,516 | $25,024 | $24,364 | $24,114 |
| Enterprise Value | $135,265 | $130,275 | $143,407 | $160,493 |
| Revenue | $33,537 | $32,364 | $31,227 | $31,686 |
| % Growth | 3.6% | 3.6% | -1.4% | – |
| Gross Profit | $21,905 | $21,148 | $20,508 | $21,541 |
| % Margin | 65.3% | 65.3% | 65.7% | 68% |
| EBITDA | $9,218 | $8,203 | $8,697 | $8,777 |
| % Margin | 27.5% | 25.3% | 27.9% | 27.7% |
| Net Income | $4,662 | $3,676 | $3,758 | $5,039 |
| % Margin | 13.9% | 11.4% | 12% | 15.9% |
| EPS Diluted | 3.61 | 2.76 | 2.82 | 3.73 |
| % Growth | 30.8% | -2.1% | -24.4% | – |
| Operating Cash Flow | $7,044 | $6,787 | $6,039 | $7,346 |
| Capital Expenditures | -$1,859 | -$1,587 | -$1,459 | -$1,368 |
| Free Cash Flow | $5,185 | $5,200 | $4,580 | $5,978 |